Chemical ablation was designed to inject chemical agents directly into solid tumors to kill
cells and is currently only used clinically for the palliative treatment of tumors. The …

Hepatocellular carcinoma (HCC) accounts for approximately 75–90% of primary liver
cancers and is the sixth most common cancer and the third leading cause of cancer-related …

Abstract Background & Aims Management of elderly patients with hepatocellular carcinoma
(HCC) has become a major concern. Some data suggest that cryoablation improves the …

Background Percutaneous ablation is an important part of management strategy for liver
tumors. While radiofrequency ablation and microwave ablation are the most widely used …

Surgical process modelling is an innovative approach that aims to simplify the challenges
involved in improving surgeries through quantitative analysis of a well-established model of …

Cryoablation refers to the destruction of tissues by rapid freezing and has been used in the
treatment of both primary and metastatic hepatic tumors for several decades. With the advent …

Image‐guided, percutaneous cryothermal ablation has become a critical modality for the
treatment of a variety of malignant and non‐malignant indications. This minimally invasive …

Cryoablation is commonly used in the kidney, lung, breast, and soft tissue, but is an
uncommon choice in the liver where radiofrequency ablation (RFA) and microwave ablation …

Hepatocellular carcinoma originating from the caudate lobe, also known as segment I
hepatocellular carcinoma, is difficult to treat because of its special location, complex …

Objective To observe the short-term efficacy and safety of CT-guided percutaneous
compound cryoablation for liver malignancies. Methods Data of 45 patients with malignant …